Free tool
FAERS Monitor: Trimethoprim
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 018679 or its brand name (Trimethoprim, Trimethoprim). Reports on generic versions are filed under their own applications.
Reports
11,863
Serious
10,877
92% of reports
Hospitalization
5,137
Death reported
1,558
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- nausea977
- off label use959
- headache910
- diarrhoea876
- malaise870
- drug ineffective801
- dyspnoea763
- pyrexia749
- vomiting746
- fatigue683
- rash633
- dizziness632
- pain623
- acute kidney injury615
- arthralgia571
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 99 |
| 2005 | 126 |
| 2006 | 139 |
| 2007 | 172 |
| 2008 | 161 |
| 2009 | 209 |
| 2010 | 238 |
| 2011 | 344 |
| 2012 | 430 |
| 2013 | 443 |
| 2014 | 603 |
| 2015 | 677 |
| 2016 | 722 |
| 2017 | 541 |
| 2018 | 848 |
| 2019 | 931 |
| 2020 | 877 |
| 2021 | 852 |
| 2022 | 842 |
| 2023 | 782 |
| 2024 | 756 |
| 2025 | 625 |
| 2026 | 445 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,296 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| acute kidney injurySignal | 615 | 7.1 | 6.6 | 3,258 |
| pyrexiaSignal | 749 | 3.8 | 3.6 | 1,596 |
| malaiseSignal | 870 | 3.5 | 3.3 | 1,599 |
| vomitingSignal | 746 | 2.8 | 2.6 | 890 |
| rashSignal | 633 | 2.6 | 2.4 | 621 |
| headacheSignal | 910 | 2.6 | 2.4 | 901 |
| arthralgiaSignal | 571 | 2.4 | 2.2 | 491 |
| diarrhoeaSignal | 876 | 2.4 | 2.3 | 742 |
| dyspnoeaSignal | 763 | 2.4 | 2.2 | 633 |
| dizzinessSignal | 632 | 2.2 | 2.1 | 447 |
| nauseaSignal | 977 | 2.2 | 2.1 | 654 |
| off label use | 959 | 1.9 | 1.8 | 456 |
| pain | 623 | 1.8 | 1.7 | 227 |
| fatigue | 683 | 1.6 | 1.4 | 140 |
| drug ineffective | 801 | 1.1 | 1.0 | 5 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.